HistoGeneX is now CellCarta Learn More


At HistoGeneX, we are here to better the lives of patients facing cancer. 

We will leverage our global laboratories and our expertise to advance immune-oncology therapies

We are eager to apply our scientific knowledge and training to provide quality results. 

We will create a thrilling workplace for our colleagues to inspire success. 

HistoGeneX Laboratories is a CAP and CLIA accredited global laboratory system located in Antwerp, Belgium and Naperville, IL, USA. HistoGeneX NV in Belgium also holds an ISO15189:2012 accreditation (BELAC 257-MED). HistoGeneX serves pharma and biotech drug development sponsors and functions as a diagnostic laboratory for oncology offices worldwide.

All HistoGeneX services and products stem from a pathology and patient care perspective. We expertly handle human biological specimens and employ innovative technologies to analyze and understand cancer for research and diagnostic applications. Our deep pathology foundation brings a real-world approach to drug development biomarker programs—a critical element within personalized medicines such as immunotherapy.

HistoGeneX Laboratories employs multiple PMA-class companion diagnostic programs. Our leadership has created and participated in the industry’s most significant targeted and immunotherapy biomarker programs in order to provide the highest quality products and services to our customers.

Subscribe to our mailing list

* indicates required